Streetbeat News

Earnings

DTIL

Precision BioSciences (NASDAQ:DTIL) reported a Q4 GAAP EPS loss of $(4.06), missing the consensus estimate of $(2.05) by 98.05%. Year-over-year, this represents a 47.27% decrease in losses from $(7.70) per share. However, Q4 sales of $7.04M fell short of the $12.48M estimate by 43.61%, marking a 33.59% decrease from the previous year's $10.60M.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:48 am

MYND

Mynd.ai reported a decrease in FY23 revenue to $413.6M from $584.6M year-over-year, with an EPS loss of $(0.09) compared to a gain of $0.05 in the previous year. The company's cash balance stands at $91.8M.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:37 am

MRNA

Moderna, Inc. (NASDAQ:MRNA) announced significant advancements in its mRNA vaccine pipeline at its fifth Vaccines Day event, including successful clinical readouts for four vaccines targeting respiratory, latent, and other viruses. The company's diverse portfolio addresses major infectious diseases with 28 vaccines in development. Key updates include progress on vaccines for CMV, EBV, HSV-2, VZV, norovirus, COVID-19, RSV, and influenza. Moderna's CMV vaccine candidate, mRNA-1647, is in a pivotal Phase 3 trial, while its EBV vaccine candidates, mRNA-1189 and mRNA-1195, are advancing towards Phase 3 trials. The company also highlighted its ongoing Phase 3 trials for COVID-19, RSV, and flu vaccines, with mRNA-1345 for RSV showing promising efficacy. Moderna estimates the total addressable market for its infectious disease vaccines at $52 billion, with significant commercial opportunities in the coming years. The company's manufacturing innovation and investment in research and development support the commercialization of its pipeline.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:32 am

HYW

Hywin Holdings Ltd. (NASDAQ:HYW) announced a strategic business transformation, shifting focus from traditional wealth management to public market funds, NAV-based products, and insurance brokerage services. The company plans to exit the distribution of asset-backed products, historically tied to real estate, due to adverse market conditions. Hywin aims to diversify income by developing health management services and expanding into consumer industries. The transformation includes a structural reorganization, eliminating around 300 positions, and the resignation of two senior executives effective March 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 10:04 am

BRSP

CVE

DRCT

ERO

FRGE

GME

MESO

WDH

XPEV

GameStop Corp. (NYSE:GME) reported Q4 earnings with net sales of $1.794 billion, missing the consensus estimate of $2.05 billion, and an EPS of 22 cents, below the expected 29 cents, causing a 14.9% drop in pre-market trading. Other stocks also moved lower in pre-market trading due to various reasons including poor financial results and special dividend announcements.

Portfolio Pulse from Avi Kapoor

March 27, 2024 | 9:39 am

NIO

NIO has revised its Q1 vehicle delivery forecast downwards from the initial range of 31,000 - 33,000 vehicles to now expecting to deliver 30,000 vehicles. This adjustment reflects challenges the company may be facing in its production or delivery processes.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 9:32 am

SNDA

Sonida Senior Living (NYSE:SNDA) reported a Q4 EPS loss of $(2.17), an improvement from $(2.79) YoY. Sales rose to $65.72M from $59.52M YoY, marking a 10.41% increase.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 9:07 am

FUL

H.B. Fuller Company (NYSE:FUL) is anticipated to release its Q1 earnings after the market closes on March 28, 2024, with analysts expecting an increase in earnings per share from 55 cents to 64 cents year-over-year, and a projected quarterly revenue of $825.03 million. Following a better-than-expected Q4 earnings report, FUL shares rose by 0.7% to $80.36. Analysts from Baird, Stifel, and JP Morgan have provided varied ratings and price targets for FUL, reflecting differing expectations for the company's stock performance.

Portfolio Pulse from Avi Kapoor

March 27, 2024 | 9:03 am

CTAS

LOCL

REE

Earnings reports for March 27, 2024, include a mix of projected losses and earnings across various sectors. Notable companies like Cintas and Lands' End are expected to report earnings, while others like Local Bounti and REE Automotive anticipate losses. The diversity of industries, from biotechnology to retail, highlights the varied financial health within the market.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 9:02 am

CCL

CTAS

GME

NCNO

Carnival, GameStop, RH, nCino, and Cintas are stocks to watch, with Carnival and Cintas expected to report earnings, GameStop posting weak Q4 results, RH anticipated to release earnings, and nCino reporting strong Q4 results and positive FY25 guidance.

Portfolio Pulse from Avi Kapoor

March 27, 2024 | 8:03 am